Molecular characterization of extended-spectrum beta-lactamases in Enterobacteriaceae from patients of two hospitals in Saxony, Germany

Journal of Medical Microbiology

Volumn 56, Issue PART 2, 2007, Pages 241-249

  Schmitt, Joachim ^a   Jacobs, Enno ^a   Schmidtt, Herbert ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PLASMID DNA;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; DNA SEQUENCE; ENTEROBACTERIACEAE; GERMANY; HOSPITAL PATIENT; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SURGICAL PATIENT;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; BETA-LACTAMS; DNA FINGERPRINTING; DNA, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; GERMANY; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; PLASMIDS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 33847200837     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.46670-0     Document Type: Article

References (47)

1. Alobwede, I., M'Zali, F. H., Livermore, D. M., Heritage, J., Todd, N. & Hawkey, P. M. (2003). CTX-M extended-spectrum β-lactamase arrives in the UK. J Antimicrob Chemother 51, 470-471.
2. Ambler, R. P., Coulson, A. F. W., Frère, J. M., Ghuysen, J.-M., Joris, B., Forsman, M., Levesque, R. C., Tiraby, G. & Waley, S. G. (1991). A standard numbering scheme for the class A β-lactamases. Biochem J 276, 269-272.
3. Babini, G. S. & Livermore, D. M. (2000). Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Western and Southern Europe in 1997-1998. J Antimicrob Chemother 45, 183-189.
4. Babini, G. S., Yuan, M., Hall, L. M. C. & Livermore, D. M. (2003). Variable susceptibility to piperacillin/tazobactam amongst Klebsiella spp. with extended-spectrum β-lactamases. J Antimicrob Chemother 51, 605-612.
5. Backman, A., Orvelid, P., Vazquez, J. A., Skold, O. & Olcen, P. (2000). Complete sequence of a beta-laclamase-encoding plasmid in Neisseria meningitidis. Antimicrob Agents Chemother 44, 210-212.
6. Bauernfeind, A., Grimm, H. & Schweighart, S. (1990). A new plasmidic cefotaximase in a clinical isolate of Escherichin coli. Infection 18, 294-298.
7. Bauernfeind, A., Rosenthal, E., Eberlein, E., Holley, M. & Schweighart, S. (1993). Spread of Klebsiella pneumoniae producing SHV-5 bcta-lactamase among hospitalized patients. Infection 21, 18-22.
8. Bedenič, B., Randegger, C., Boras, A. & Hächler, H. (2001). Comparison of five different methods for detection of SHV extended-spectrum β-lactamases. J Chemother 13, 24-33.
9. Bonnet, R. (2004). Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 48, 1-14.
10. Bradford, P. A. (2001). Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 14, 933-951.
11. Bush, K. (2001). New β-lactamasecs in Gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin Infect Dis 32, 1085-1089.
12. Bush, K., Jacoby, G. A. & Medeiros, A. A. (1995). A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 39, 1211-1233.
13. Chang, F.-Y., Siu, L. K., Fung, C.-P., Huang, M.-H. & Ho, M. (2001). Diversity of SHV and TEM β-lactamases in Klebsiella pneumoniae: gene evolution in Northern Taiwan and two novel β-lactamases, SHV-25 and SHV-26. Antimicrob Agents Chemother 45, 2407-2413.
14. Coque, T. M., Oliver, A., Perez-Diaz, J. C., Baquero, F. & Canton, R. (2002). Genes encoding TEM-4, SHV-2, and CTX-M-10 extended-spectrum beta-lactamases are carried by multiple Klebsiella pneumoniae clones in a single hospital (Madrid, 1989 to 2000). Antimicrob Agents Chemother 46, 500-510.
15. De Champs, C., Chanal, C., Sirot, D., Baraduc, R., Romaszko, J. P., Bonnet, R., Plaidy, A., Boyer, M., Carroy, E. & other authors (2004). Frequency and diversity of class A extended-spectrum beta-lactamases in hospitals of the Auvergne, France: a 2 year prospective study. J Antimicrob Chemother 54, 634-639.
16. Deutsches Institut für Normung (1989). Methoden zur Empfindlichkeitsprüfung von mikrobiellen Krankheitserregern (außer Mykobakterien) gegen Chemotherapeutika. Teil 6: Bestimmung der minimalen Hemmkonzentration nach der Agar-Dilutionsmethode. DIN-58940-6. Berlin: Beuth-Verlag.
17. Domenico, P., Marx, J. L., Schoch, P. E. & Cunha, B. A. (1992). Rapid plasmid DNA isolation from mucoid Gram-negative bacteria. J Clin Microbiol 30, 2859-2863.
18. Edelstein, M., Pimkin, M., Palagin, I., Edelstein, I. & Stratchounski, L. (2003). Prevalence and molecular epidemiology of CTX-M extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob Agents Chemother 47, 3724-3732.
19. Elwell, L. P. & Falkow, S. (1986). The characterization of R plasmids and the detection of plasmid-spccified genes. In Antibiotics in Laboratory Medicine, 2nd edn, pp. 683-721. Edited by V. Lorian. Baltimore: Williams and Wilkins.
20. Fournier, B., Lu, C. Y., Lagrange, P. H., Krishnamoorthy, R. & Phillippon, A. (1995). Point mutation in the Pribnow-box, the molecular basis of β-lactamase overproduction in Klebsiella oxytoca. Antimicrob Agents Chemother 39, 1365-1368.
21. Geiss, H. K., Mack, D. & Seifert, H. (2003). Konsensuspapier zur Identifizierung von speziellen Resistenzmechanismen und zur Interpretation von Ergebnissen der Antibiotikaempfind-lichkeitstestung bei grampositiven und gramnegativen Erregern. Der Mikrobiologe 13, 222-239 (in German).
22. Gniadkowski, M. (2001). Evolution and epidemiology of extended-spectrum β-lactamases (ESBLs) and ESBL-producing microorganisms. Clin Microbiol Infect 7, 597-608.
23. Gniadkowski, M., Schneider, I., Jungwirth, R., Hryniewicz, W. & Bauernfeind, A. (1998a). Ceftazidime resistant Enterobacteriaceae isolates from three Polish hospitals: identification of three novel TEM- and SHV-5-type extended-spectrum β-lactamases. Antimicrob Agents Chemother 42, 514-520.
24. Gniadkowski, M., Schneider, I., Palucha, A., Jungwirth, R., Mikiewicz, B. & Bauernfeind, A. (1998b). Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing beta-lactamase that is closely related to the CTX-M-I/MEN-I enzyme. Antimicrob Agents Chemother 42, 827-832.
25. Hall, T. A. (1999). BioEdit: a user-friendly biologic sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 41, 95-98.
26. Heritage, J., M'Zali, F. H., Gascoyne-Binzi, D. & Hawkey, P. M. (1999). Evolution and spread of SHV extended-spectrum β-lactamases in Gram-negative bacteria. J Antimicrob Chemother 44, 309-318.
27. Howard, C., van Daal, A., Kelly, G., Schooneveldt, J., Nimmo, G. & Giffard, P. M. (2002). Identification and minisequencing-based discrimination of SHV β-lactamases in nosocomial infection-associated Klebsiella pneumoniae in Brisbane, Australia. Antimicrob Agents Chemother 46, 659-664.
28. Jacoby, G. A. & Medeiros, A. A. (1991). More extended-spectrum β-lactamases. Antimicrob Agents Chemother 35, 1697-1704.
29. Jeong, S. H,, Kim, W. M., Chang, C. L., Kim, J. M., Lee, K., Chong, Y., Hwang, H. Y., Baek, Y. W., Chung, H. K. & other authors (2001). Neonatal intensive care unit outbreak caused by a strain of Klebsiella oxytoca resistant to aztreonam due to overproduction of chromosomal beta-lactamase. J Hosp Infect 48, 281-288.
30. Kim, Y.-K., Pai, H., Lee, H.-J., Park, S.-E., Choi, E.-H., Kim, J., Kim, J. H. & Kim, E. C. (2002). Bloodstream infections by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob Agents Chemother 46, 1481-1491.
31. Kim, J., Lim, Y.-M., Rheem, I., Lee, Y., Lee, J. C., Seol, S. Y., Lee, Y. C. & Cho, D. T. (2005). CTX-M and SHV-12 beta-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea. FEMS Microbiol Lett 245, 93-98.
32. Kliebe, C., Nies, B. A., Meyer, J. F., Tolxdorff-Neutzling, R. M. & Wiedemann, B. (1985). Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob Agents Chemother 28, 302-307.
33. Leverstein-van Hall, M. A., Fluit, A. C., Paauw, A., Box, A. T. A., Brisse, S. & Verhoef, J. (2002). Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VlTEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp. J Clin Microbiol 40, 3703-3711.
34. Liu, C. P., Wang, N. Y., Lee, C. M., Weng, L. C., Tseng, H. K., Liu, C. W., Chiang, C. S. & Huang, F. Y. (2004). Nosocomial and community-acquired Enterobacter cloacae bloodstream infection: risk factors for and prevalence of SHV-12 in multiresistant isolates in a medical centre. J Hosp Infect 58, 63-77.
35. Livermore, D. M. (1995). β-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 8, 557-584.
36. Mammeri, H., Laurans, G., Eveillard, M., Castelain, S. & Eb, F. (2001). Coexistence of SHV-4- and TEM-24-producing Enterobacter aerogenes strains before a large outbreak of TEM-24-producing strains in a French hospital. J Clin Microbiol 39, 2184-2190.
37. Mulvey, M. R., Bryce, E., Boyd, D., Ofner-Agostini, M., Christianson, S., Simor, A. E. & Paton, S. (2004). Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals. Antimicrob Agents Chemother 48, 1204-1214.
38. Ndugulile, F., Jureen, R., Harthug, S., Urassa, W. & Langeland, N. (2005). Extended spectrum β-lactamases among Gram-negative bacteria of nosocomial origin from an intensive care unit of a tertiary health facility in Tanzania. BMC Infect Dis 5, 86.
39. Nüesch-Inderbinen, M., Hächler, H. & Kayser, F. H. (1996). Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur J Clin Microbiol Inject Dis 15, 398-402.
40. Nüesch-Inderbinen, M., Kayser, F. H. & Hächler, H. (1997). Survey and molecular genetics of SHV β-actamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12. Antimicrob Agents Chemother 41, 943-949.
41. Paterson, D. L., Ko, W.-C., von Gottenberg, A., Casellas, J. M., Mulazimoglu, L., Klugman, K. P., Bonomo, R. A., Rice, L. B., McCormack, J. G. & Yu, V. L. (2001). Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol 39, 2206-2212.
42. Paterson, D. L., Hujer, K. M., Hujer, A. M., Yeiser, B., Bonomo, M. D., Rice, L. B., Bonomo, R. A. & International Klebsiella Study Group (2003). Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and wide-spread prevalence of SHV- and CTX-M-type beta-lactamases. Antimicrob Agents Chemother 47, 3554-3560.
43. Pėduzzi, J., Barthėlémy, M., Tiwar, K., Mattioni, D. & Labia, R. (1989). Structural features related to hydrolytic activity against ceftazidime of plasmid-mediated SHV-type CAZ-5 beta-lactamase. Antimicrob Agents Chemother 33, 2160-2163.
44. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
45. Thomson, K. S. & Moland, E. S. (2001). Cefepime, piperacillin-tazobactam and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 45, 3548-3554.
46. Witte, W. & Mielke, M. (2003). β-Laktamasen mit breitem Wirkungsspektrum: Grundlagen, Epidemiologie, Schlußfolgerungen für die Prävention. Bundesgesundheitsbl-Gesundheitsforsch-Gesund heitsschutz 46, 881-890 (in German).
47. Wu, T.-L., Siu, L. K., Su, L-H., Lauderdale, T. L., Lin, F. M., Leu, H.-S., Lin, T.-Y. & Ho, M. (2001). Outer membrane protein change combined with co-existing TEM-1 and SHV-1 β-lactamases lead to false identification of ESBL-producing Klebsiella pneumoniae. J Antimicrob Chemother 47, 755-761.